Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Guardant Health (Nasdaq: GH), a leading precision oncology company, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY. The company's management will take part in a fireside chat on Thursday, September 5th at 11:30 a.m. ET.
Interested parties can access live and archived webcasts of the sessions on the 'Investors' section of the company's website at www.guardanthealth.com. This event provides an opportunity for Guardant Health to showcase its advancements in precision oncology and engage with industry professionals and investors.
Guardant Health (Nasdaq: GH), un'azienda leader nella oncologia di precisione, ha annunciato la sua partecipazione al 22° Annual Global Healthcare Conference di Morgan Stanley a New York, NY. La direzione dell'azienda parteciperà a una conversazione informale il giovedì 5 settembre alle 11:30 a.m. ET.
Le parti interessate possono accedere alle dirette e alle registrazioni dei webcast delle sessioni nella sezione 'Investitori' del sito web dell'azienda all'indirizzo www.guardanthealth.com. Questo evento offre l'opportunità a Guardant Health di mettere in mostra i propri progressi nell'oncologia di precisione e di interagire con professionisti del settore e investitori.
Guardant Health (Nasdaq: GH), una empresa líder en oncología de precisión, ha anunciado su participación en la 22ª Conferencia Anual Global de Atención Médica de Morgan Stanley en Nueva York, NY. La dirección de la empresa participará en una charla informal el jueves 5 de septiembre a las 11:30 a.m. ET.
Las partes interesadas pueden acceder a las retransmisiones en vivo y archivadas de las sesiones en la sección 'Inversores' del sitio web de la empresa en www.guardanthealth.com. Este evento ofrece a Guardant Health la oportunidad de mostrar sus avances en oncología de precisión y relacionarse con profesionales de la industria e inversores.
Guardant Health (Nasdaq: GH), 정밀 종양학 분야의 선도 기업이 뉴욕, NY에서 열리는 모건 스탠리 제22회 연례 글로벌 건강 관리 회의에 참가한다고 발표했습니다. 회사의 경영진은 9월 5일 목요일 오전 11시 30분 ET에 진행되는 화상 대화에 참석할 예정입니다.
관심 있는 분들은 회사 웹사이트 www.guardanthealth.com의 '투자자' 섹션에서 세션의 실시간 및 아카이브 웹캐스트에 접근할 수 있습니다. 이번 이벤트는 Guardant Health가 정밀 종양학의 발전을 선보이고 업계 전문가 및 투자자와 소통할 수 있는 기회를 제공합니다.
Guardant Health (Nasdaq: GH), une entreprise de pointe dans le domaine de l'oncologie de précision, a annoncé sa participation à la 22e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley à New York, NY. La direction de l'entreprise participera à une discussion informelle le jeudi 5 septembre à 11h30 ET.
Les parties intéressées peuvent accéder aux webcasts en direct et archivés des sessions dans la sous-section 'Investisseurs' du site web de l'entreprise à l'adresse www.guardanthealth.com. Cet événement offre à Guardant Health l'opportunité de présenter ses avancées en oncologie de précision et d'interagir avec des professionnels de l'industrie et des investisseurs.
Guardant Health (Nasdaq: GH), ein führendes Unternehmen im Bereich der präzisen Onkologie, hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley in New York, NY, angekündigt. Die Unternehmensleitung wird an einem informellen Gespräch am Donnerstag, den 5. September um 11:30 Uhr ET teilnehmen.
Interessierte Parteien können die Live- und archivierten Webcasts der Sitzungen im 'Investoren'-Bereich der Unternehmenswebsite unter www.guardanthealth.com einsehen. Diese Veranstaltung bietet Guardant Health die Möglichkeit, seine Fortschritte in der präzisen Onkologie zu präsentieren und mit Branchenprofis und Investoren in Kontakt zu treten.
- None.
- None.
Guardant Health’s management is scheduled to participate in a fireside chat on Thursday, September 5th at 11:30 a.m. ET. Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240827242654/en/
Investor Contact:
Zarak Khurshid
investors@guardanthealth.com
Media Contact:
Melissa Marasco
press@guardanthealth.com
+1 650-647-3711
Source: Guardant Health, Inc.
FAQ
When is Guardant Health participating in the Morgan Stanley Global Healthcare Conference?
Where can I watch Guardant Health's fireside chat at the Morgan Stanley conference?
What type of event is Guardant Health (GH) participating in at the Morgan Stanley conference?
Where is the Morgan Stanley Global Healthcare Conference being held?
